Short- and long-term cost and utilization of health care resources in Parkinson's disease in the UK

Weir, S., Samnaliev, M., Kuo, T.-C., Tierney, T. S., Walleser Autiero, S., Taylor, R. S. and Schrag, A. (2018) Short- and long-term cost and utilization of health care resources in Parkinson's disease in the UK. Movement Disorders, 33(6), pp. 974-981. (doi: 10.1002/mds.27302) (PMID:29603405)

[img]
Preview
Text
193201.pdf - Accepted Version

731kB
[img]
Preview
Text
193201Supp.pdf - Supplemental Material

279kB

Abstract

Background: There is currently no robust long‐term data on costs of treating patients with Parkinson's disease. The objective of this study was to report levels of health care utilization and associated costs in the 10 years after diagnosis among PD patients in the United Kingdom. Methods: We undertook a retrospective population‐based cohort study using linked data from the UK Clinical Practice Research Datalink and Hospital Episode Statistics databases. Total health care costs of PD patients were compared with those of a control group of patients without PD selected using 1:1 propensity score matching based on age, sex, and comorbidity. Results: Between 1994 and 2013, 7271 PD patients who met study inclusion criteria were identified in linked Clinical Practice Research Datalink‐Hospital Episode Statistics; 7060 were matched with controls. The mean annual health care cost difference (at 2013 costs) between PD patients and controls was £2471 (US$3716) per patient in the first year postdiagnosis (P < 0.001), increasing to £4004 (US$6021) per patient (P < 0.001) 10 years following diagnosis because of higher levels of use across all categories of health care utilization. Costs in patients with markers of advanced PD (ie, presence of levodopa‐equivalent daily dose > 1100 mg, dyskinesias, falls, dementia, psychosis, hospital admission primarily due to PD, or nursing home placement) were on average higher by £1069 (US$1608) per patient than those with PD without these markers. Conclusions: This study provides comprehensive estimates of health care costs in PD patients based on routinely collected data. Health care costs attributable to PD increase in the year following diagnosis and are higher for patients with indicators of advanced disease.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Taylor, Professor Rod
Authors: Weir, S., Samnaliev, M., Kuo, T.-C., Tierney, T. S., Walleser Autiero, S., Taylor, R. S., and Schrag, A.
College/School:College of Medical Veterinary and Life Sciences > Institute of Health and Wellbeing > MRC/CSO SPHSU
Journal Name:Movement Disorders
Publisher:Wiley
ISSN:0885-3185
ISSN (Online):1531-8257
Published Online:30 March 2018
Copyright Holders:Copyright © 2018 International Parkinson and Movement Disorder Society
First Published:First published in Movement Disorders 33(6):974-981
Publisher Policy:Reproduced in accordance with the copyright policy of the publisher

University Staff: Request a correction | Enlighten Editors: Update this record